+ Bookmark This Page  
Preferences  |  10:36 AM
  1. Home
  2. Latest News
  3. Submit Press Release
  4. Search Jobs
  5. Search Businesses
  1. News Home
  2. News Archive
  3. By Category
  4. By Location
  5. By Date
  6. By Tag
  7. Newsletter
  8. 40,000 RSS Feeds
  9. Submit Free Press Release
 
Filter News
Category

Country

State / Province
Select Country First

City / Town
Select State First

Therapeutics for Inflammatory Diseases: Projected to Increase to $35.5 billion in 2010

Therapeutics for Inflammatory Diseases: Projected to Increase to $35.5 billion in 2010, says new report available from ReportBuyer.com.
 

FOR IMMEDIATE RELEASE

PRLog (Press Release)Jun 05, 2007 – Report Buyer, the online destination for business intelligence for major industry sectors has now added a new market report titled ‘Therapeutics for Inflammatory Diseases’
http://www.reportbuyer.com/search/results.html?q=BCC00103&x=56&y=10

Findings in the 183 page Report include:
•   The market for anti-inflammatory drugs to treat the diseases covered in this report was approximately $21.9 billion in 2005 and is projected to increase to $35.5 billion in 2010.
•   The fastest growing disease category for anti-inflammatory treatment is psoriasis, which saw the first introductions of expensive monoclonal antibody products in the last two years.
•   The largest market by far in 2005 is that for the treatment of asthma and chronic obstructive pulmonary disease, which accounted for approximately 36% of the total market in 2005. The asthma/COPD market will remain the largest in 2010, but will decline to 31.4% of the total of market by the end of the forecast period.

Summary of the Report:
•   Analyzes and assesses marketed and in-development prescription, systemic anti-infl ammatory drugs indicated for the following diseases-ankylosing spondylitis, asthma/chronic obstructive pulmonary disease (COPD), infl ammatory bowel diseases, multiple sclerosis, psoriasis and rheumatoid arthritis.
•   Provides an overview of the categories of anti-inflammatory drugs, including biological anti-inflammatory products, their methods of activity, usage and sales. Markets for antiinfl ammatory drugs by disease, including sales and forecasts as well as discussion of products for each indication that are in Phase II and later trials.
•   Discusses industry structure including the impact of the removal of Vioxx and Bextra from the marketplace. Also discussed is the issue of direct-to-consumer (DTC) marketing.
•   Profiles companies emphasizing leaders in the pharmaceutical and biotechnology industry in the research and development of anti-inflammatory drugs and the innovative products they have launched or have in development.

Content:
Introduction
Executive Summary
Overview
Applications And Products
Industry
Company Profiles
List Of Figures

Therapeutics for Inflammatory Diseases is available in PDF format from Report Buyer. For more information go to: http://www.reportbuyer.com/search/results.html?q=BCC0010 ...

Report Buyer product ID: BCC00103

About Report Buyer.
Report Buyer is a UK-based independent online store supplying business information on major industry sectors. These include the Automotive Industry, Banking & Finance, Energy & Utilities, Food & Drink, Telecoms and Pharma & Healthcare. The website now carries over 24,000 business information products, including market reports, studies and books. Report Buyer is the intelligent way to buy market research making it an essential resource for executives and information buyers worldwide. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest.
# # # + Share This Article Click to see PDF Version of this Press Release

Email to a Friend   Email to Author       Previous News   Next News


Issued By:Report Buyer
Website:http://www.reportbuyer.com
Email:Click to contact author
Phone:0207 060 7474
City/Town:London
State/Province:London
Country:United Kingdom
Categories:Health
Tags:Therapeutics For Inflammatory Diseases

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog.Org can't be held liable for the contents of the press releases.   Report Abuse


Related

An Organization Launched With The Goal Of Serving The Cancer Community At Its Best.

Exercise Franchise SuperSlow Zone® San Jose Showcases Its Strength Training At Senior Health Fair

Exercise Franchise SuperSlow Zone® CEO Madeline Ross To Speak At Corporate Wellness Conference

Weekend Walk-In Clinic Provides Convenient Treatment Option for Injured Athletes

HIBCC Welcomes Turkey Affiliate


Most Viewed (Last 7 days)

LifeCaps to Visit Houston After Hurricane Ike to Promote Survival Kits - 1457 views

A third grader writes about Tourette Syndrome - 1106 views

Homemade Halloween Decorations Create Halloween Fun - 930 views

New Music Awards, Announcing The Swi Awards - 748 views

Untold Truths about Asperger’s Syndrome Unveiled in Xlibris Self-Published Release, ‘Aspie’ - 527 views



Previous News

Next News

Are you a Journalist?


For Businesses ...


Tutorial on Free Marketing




  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Use
  5. Copyright Notice